Escalon Medical Corp
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or … Read more
Market Cap & Net Worth: Escalon Medical Corp (ESMC)
Escalon Medical Corp (OTCQB:ESMC) has a market capitalization of $1.19 Million ($1.19 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #35710 globally and #11628 in its home market, demonstrating a -11.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Escalon Medical Corp's stock price $0.16 by its total outstanding shares 7415329 (7.42 Million).
Escalon Medical Corp Market Cap History: 2015 to 2025
Escalon Medical Corp's market capitalization history from 2015 to 2025. Data shows change from $7.86 Million to $1.19 Million (-18.27% CAGR).
Escalon Medical Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Escalon Medical Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.10x
Escalon Medical Corp's market cap is 0.10 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
11.24x
Escalon Medical Corp's market cap is 11.24 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $778.61K | $11.58 Million | -$1.15 Million | 0.07x | N/A |
| 2017 | $1.56 Million | $11.23 Million | -$726.89K | 0.14x | N/A |
| 2018 | $889.84K | $11.40 Million | $583.67K | 0.08x | 1.52x |
| 2019 | $1.11 Million | $9.63 Million | -$250.02K | 0.12x | N/A |
| 2020 | $926.92K | $9.40 Million | -$650.28K | 0.10x | N/A |
| 2021 | $797.15K | $10.47 Million | -$52.02K | 0.08x | N/A |
| 2022 | $472.36K | $10.70 Million | $18.08K | 0.04x | 26.12x |
| 2023 | $1.94 Million | $12.18 Million | $456.83K | 0.16x | 4.24x |
| 2024 | $1.19 Million | $11.98 Million | -$125.26K | 0.10x | N/A |
| 2025 | $1.19 Million | $12.05 Million | $105.53K | 0.10x | 11.24x |
Competitor Companies of ESMC by Market Capitalization
Companies near Escalon Medical Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Escalon Medical Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Escalon Medical Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Escalon Medical Corp's market cap moved from $7.86 Million to $ 1.19 Million, with a yearly change of -18.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.19 Million | 0.00% |
| 2024 | $1.19 Million | -38.72% |
| 2023 | $1.94 Million | +309.89% |
| 2022 | $472.36K | -40.74% |
| 2021 | $797.15K | -14.00% |
| 2020 | $926.92K | -16.67% |
| 2019 | $1.11 Million | +25.00% |
| 2018 | $889.84K | -42.83% |
| 2017 | $1.56 Million | +99.90% |
| 2016 | $778.61K | -90.09% |
| 2015 | $7.86 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Escalon Medical Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.19 Million USD |
| MoneyControl | $1.19 Million USD |
| MarketWatch | $1.19 Million USD |
| marketcap.company | $1.19 Million USD |
| Reuters | $1.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.